Impaired Chaperone-Mediated Autophagy Accelerates Intervertebral Disc Degeneration by Inducing MIDN Accumulation to Target TSC2 for Proteasomal Degradation
What this study shows
Loss of chaperone-mediated autophagy lets its substrate midnolin (MIDN) accumulate; MIDN binds TSC2 and drives its proteasomal degradation independently of ubiquitination, de-repressing mTORC1 and causing senescence, SASP and matrix loss in disc cells. MIDN knockdown, LAMP2A overexpression or rapamycin each blocked the degeneration - a new upstream route to mTORC1 hyperactivation.
At a glance
| Evidence type | A Animal model Marked A because it is an animal intervention or observation study measuring an organismal outcome (model: Human nucleus pulposus cells; rat caudal needle-puncture model); the code names the system studied -- animal work can be rigorous and still not be human data. |
| Study type | 4 - Animal Study |
| Model system | Human nucleus pulposus cells; rat caudal needle-puncture model |
| Journal | Advanced Science |
| Year | 2026 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1002/advs.77428 · PMID 42658647 |
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | MIDN knockdown (shRNA), LAMP2A overexpression (CMA activation), rapamycin |
| Target | TSC2 / mTORC1 (via midnolin, MIDN) |
| Model | Human cells; rat |
| Effect | Impaired CMA -> MIDN accumulation -> TSC2 degradation -> mTORC1 hyperactivation -> senescence, SASP and matrix loss; blocked by MIDN knockdown, LAMP2A overexpression or rapamycin |
In the Atlas
Related topics
Links in the pathway map
- Supports mTORC1 activates Senescence-associated secretory phenotype (SASP)
- Supports TSC1/TSC2 inhibits mTORC1
More studies on this topic
- Lysosomal mTORC2/PHLPP1/Akt regulate chaperone-mediated autophagy (2015)
- mTOR regulates the pro-tumorigenic senescence-associated secretory phenotype by promoting IL1A translation (2015)
- Spatial coupling of mTOR and autophagy augments secretory phenotypes (2011)
- Therapeutic reversal of cellular senescence: A systematic review of senolytics, senomorphics and anti-ageing therapies in human clinical trials (2026)
Was this page useful?
Thank you. Your answer was counted anonymously.